Clough Capital Partners L P Veracyte, Inc. Transaction History

Clough Capital Partners L P

$924 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $1.34 Million - $1.72 Million	-63,718 Reduced 18.74%	276,260 $7.04 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $473,381 - $641,525	23,002 Added 7.26%	339,978 $7.58 Million
Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $1.1 Million - $2.16 Million	-72,019 Reduced 18.51%	316,976 $7.52 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $5.53 Million - $9.3 Million	333,500 Added 600.96%	388,995 $6.46 Million
Q2 2022 Aug 16, 2022	SELL	$15.45 - $29.52 $1.42 Million - $2.72 Million	-92,175 Reduced 62.42%	55,495 $1.1 Million
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $789,620 - $1.53 Million	-35,990 Reduced 19.6%	147,670 $4.07 Million
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $2.61 Million - $3.89 Million	-72,400 Reduced 28.27%	183,660 $7.57 Million
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $1.04 Million - $1.55 Million	29,200 Added 12.87%	256,060 $11.9 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $2.04 Million - $3.51 Million	62,000 Added 37.61%	226,860 $9.07 Million
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $1.26 Million - $2.3 Million	-28,300 Reduced 14.65%	164,860 $8.86 Million
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $1 Million - $1.91 Million	-30,800 Reduced 13.75%	193,160 $9.45 Million
Q3 2020 Nov 17, 2020	BUY	$26.73 - $35.67 $2.41 Million - $3.21 Million	90,100 Added 67.31%	223,960 $7.28 Million
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $939,417 - $1.35 Million	48,200 Added 56.27%	133,860 $3.47 Million
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $2.2 Million - $4.12 Million	-136,480 Reduced 61.44%	85,660 $2.08 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $1.49 Million - $2.16 Million	-71,900 Reduced 24.45%	222,140 $6.2 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $798,212 - $1.03 Million	33,440 Added 12.83%	294,040 $7.06 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $1.98 Million - $2.55 Million	89,400 Added 52.22%	260,600 $7.43 Million
Q1 2019 May 15, 2019	SELL	$12.0 - $25.76 $2.7 Million - $5.81 Million	-225,400 Reduced 56.83%	171,200 $4.28 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $883,890 - $1.43 Million	96,600 Added 32.2%	396,600 $4.99 Million
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $2.87 Million - $3.79 Million	300,000 New	300,000 $2.87 Million

Others Institutions Holding VCYT

# of Institutions

320

Shares Held

80.6M

Call Options Held

134K

Put Options Held

13.3K

Black Rock Inc. New York, NY

7.79M
Shares

$324 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.75M
Shares

$322 Million
0.0% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

5.02M
Shares

$209 Million
0.27% of portfolio
Wellington Management Group LLP Boston, MA

4.23M
Shares

$176 Million
0.03% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

4.2M
Shares

$175 Million
1.46% of portfolio

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Account